Chemistry Labs

Biochemistry and biomedical chemistry

Structure-based drug design

Structure-based design uses a macromolecular structure to generate and test hypotheses about ligand recognition.

IntuitionIntuition: the central idea

Structure-based design uses a macromolecular structure to generate and test hypotheses about ligand recognition.

Explore the schematic model; it illustrates a concept rather than replacing experimental evidence.

SchoolSchool level: key concepts and a first application

Definition: Core concept

A workflow may combine target validation, experimental or predicted structure, pocket analysis, docking, chemical synthesis and biochemical or cellular assays.

Binding pockets are mapped from experiment or prediction; fragments and hits are optimized by iteration of synthesis, structure determination and assays.

Key terms and meaning
TermInterpretation
Binding pocketA region of a macromolecule that can host a ligand.
DockingPredicting ligand poses and ranking them with a scoring function.
Hits and leadsInitial active molecules and improved candidates for optimization.

Example: Apply the idea

A ligand has KD=10−7K_D=10^{-7} M. Estimate its standard binding free energy at 298 K using RT≈2.48RT\approx2.48 kJ mol⁻¹.

Solution

Taking the 1 M standard-state ratio, ΔG∘≈RTln⁡(10−7)≈−40\Delta G^\circ\approx RT\ln(10^{-7})\approx-40 kJ mol⁻¹. Docking scores are not calibrated binding free energies.

UndergraduateUniversity level: quantitative description

ΔGbind=RTln⁡KD\Delta G_{\mathrm{bind}}=RT\ln K_D

Docking scores are empirical approximations; free-energy estimates improve when conformational sampling, protonation and solvent are treated more completely.

AdvancedAdvanced: assumptions and mechanistic detail

Advanced structure-based workflows combine experimental density, molecular-dynamics sampling, free-energy methods and iterative medicinal chemistry. The hypothesis cycle matters more than any single score.

ResearchResearch frontier: open questions and current practice

References